Cadrenal Therapeutics, Inc. announced its membership in the Corporate Council of the Anticoagulation Forum (AC Forum) on October 23, 2024. The AC Forum is recognized as the largest professional organization for anticoagulation specialists, dedicated to advancing the quality and safety of chronic anticoagulation care globally.
Through this participation, Cadrenal Therapeutics will collaborate with the AC Forum to identify and address unmet clinical needs, share cutting-edge research, and promote advocacy and educational initiatives. These efforts are aimed at improving outcomes for patients on anticoagulants among the organization's 15,000 healthcare professional members.
Quang X. Pham, Chief Executive Officer of Cadrenal Therapeutics, stated that this membership reflects a shared commitment to transforming anticoagulation care. The company anticipates contributing to programs that advance safer, more effective care and inform about ongoing research and anticoagulation best practice guidelines.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.